HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
NEO
NeoGenomics, Inc.
NEO lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
NEO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Weak |
NEO's revenue is currently healthy, and its profitability is stable, but its cash flow and balance sheet are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
NEO PE Valuation
NEO has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
NEO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
NEO has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
NEO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.29 | — |
| Q3 2026 | -$0.25 | +$0.63 |
| Q2 2026 | -$0.40 | +$0.41 |
| Q1 2026 | -$0.77 | -$0.16 |
| Q4 2025 | -$0.84 | -$0.22 |
| Q3 2025 | -$0.88 | -$0.27 |
| Q2 2025 | -$0.81 | -$0.19 |
| Q1 2025 | -$0.61 | +$0.05 |
| Q4 2024 | -$0.62 | +$0.08 |
NEO is still losing money, but far less than before: $0.25 per share over the past year, against $1.28 at its worst in late 2022.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over NEO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
NEO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $209.3M | +11% |
| Q2 2026 | $201.7M | +11% |
| Q1 2026 | $186.7M | +11% |
| Q4 2025 | $190.2M | +11% |
| Q3 2025 | $187.8M | +12% |
| Q2 2025 | $181.3M | +10% |
| Q1 2025 | $168M | +7.5% |
| Q4 2024 | $172M | +11% |
NEO's revenue has grown year over year for 19 quarters in a row: $209M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.8% | +11 points |
| Q2 2026 | -4.8% | +21 points |
| Q1 2026 | -9.8% | +6.8 points |
| Q4 2025 | -7% | +3.6 points |
| Q3 2025 | -14% | -1.8 points |
| Q2 2025 | -26% | -13 points |
| Q1 2025 | -17% | +3 points |
| Q4 2024 | -11% | +1.2 points |
NEO has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over NEO on cash generation, producing positive trailing cash flow while its opponent burns cash.
NEO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$20.7M | -3724% |
| Q2 2026 | $11.7M | -16% |
| Q1 2026 | -$13.1M | +$16.7M |
| Q4 2025 | -$6.5M | -$4.7M |
| Q3 2025 | $570K | +$2.1M |
| Q2 2025 | $14M | +1621% |
| Q1 2025 | -$29.8M | +$1.7M |
| Q4 2024 | -$1.8M | -117% |
NEO has burned cash in most quarters: −$29M over the past year, against −$17M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over NEO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
NEO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -2.2M shares |
| 1 year | +0.1% | +172K shares |
| 3 years | +2.3% | +2.9M shares |
| 5 years | +4.9% | +6M shares |
| Available history | +19% | +20.8M shares |
NEO has 129M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
NEO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 14.9x | High |
| Q2 2021 | 14.7x | High |
| Q1 2021 | -6.3x | Net Cash |
| Q4 2020 | -2.7x | Net Cash |
| Q3 2020 | -4.0x | Net Cash |
| Q2 2020 | -9.4x | Net Cash |
| Q1 2020 | 0.5x | Very low |
| Q4 2019 | -1.6x | Net Cash |
NEO's net debt is about 15 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
NEO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 38.7 | Neutral |
NEO's weekly RSI is 56 (neutral) and its Stochastic is 39 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
NEO PE vs Healthcare Sector
| Metric | NEO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
NEO has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
NEO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.3 | 4.2% below |
| 20 week MA | $16.7 | 0.8% below |
| 50 week MA | $12.9 | 28% above |
| 100 week MA | $11.3 | 46% above |
| 200 week MA | $13.4 | 24% above |
NEO has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
NEO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.8 | $55.4 | +86% |
| 2021 | $55.4 | $34.3 | -38% |
| 2022 | $34.3 | $9.17 | -73% |
| 2023 | $9.17 | $16.2 | +76% |
| 2024 | $16.2 | $16.8 | +4% |
| 2025 | $16.8 | $12.3 | -27% |
| 2026 YTD | $12.3 | $16.5 | +35% |
NEO has the edge over HIMS on returns for 2026, with the stronger performance.